(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.31%) $82.75
(6.24%) $2.04
(0.01%) $2 347.40
(-0.23%) $27.47
(3.88%) $957.85
(-0.23%) $0.933
(-0.40%) $10.98
(-0.56%) $0.796
(1.67%) $93.40
2.14% $ 11.45
@ $12.36
Ausgestellt: 14 Feb 2024 @ 15:30
Rendite: -7.36%
Vorheriges Signal: Feb 12 - 21:00
Vorheriges Signal:
Rendite: -1.98 %
Live Chart Being Loaded With Signals
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation...
Stats | |
---|---|
Tagesvolumen | 189 969 |
Durchschnittsvolumen | 204 745 |
Marktkapitalisierung | 368.35M |
EPS | $0 ( 2024-04-25 ) |
Nächstes Ertragsdatum | ( $0.0300 ) 2024-05-16 |
Last Dividend | $0.100 ( 2022-01-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 42.41 |
ATR14 | $0.0250 (0.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Moorhead Daniel J | Sell | 6 084 | Common Stock |
2024-03-25 | Lucsok Anna | Sell | 7 672 | Common Stock |
2024-03-25 | Sandgaard Thomas | Sell | 2 268 | Common Stock |
2024-03-05 | Moorhead Daniel J | Buy | 5 000 | Common Stock (Restricted Stock Award) |
2024-01-27 | Lucsok Anna | Buy | 5 000 | Common Stock (Restricted Stock Award) |
INSIDER POWER |
---|
-38.23 |
Last 100 transactions |
Buy: 368 705 | Sell: 936 982 |
Volumen Korrelation
Zynex Inc Korrelation
10 Am meisten positiv korreliert | |
---|---|
MMAC | 0.896 |
BOCH | 0.863 |
BMRN | 0.848 |
CTRN | 0.841 |
STRO | 0.838 |
XEL | 0.832 |
CAAS | 0.826 |
ISRG | 0.821 |
AMRB | 0.814 |
GLSI | 0.812 |
10 Am meisten negativ korreliert | |
---|---|
APOP | -0.971 |
RMRM | -0.939 |
MAGS | -0.936 |
TDAC | -0.897 |
CMLF | -0.868 |
SVOK | -0.836 |
EMBCV | -0.824 |
TLGT | -0.823 |
SPRT | -0.82 |
TALS | -0.82 |
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Zynex Inc Korrelation - Währung/Rohstoff
Zynex Inc Finanzdaten
Annual | 2023 |
Umsatz: | $184.32M |
Bruttogewinn: | $145.96M (79.19 %) |
EPS: | $0.270 |
FY | 2023 |
Umsatz: | $184.32M |
Bruttogewinn: | $145.96M (79.19 %) |
EPS: | $0.270 |
FY | 2022 |
Umsatz: | $158.17M |
Bruttogewinn: | $126.16M (79.77 %) |
EPS: | $0.440 |
FY | 2021 |
Umsatz: | $130.30M |
Bruttogewinn: | $102.98M (79.03 %) |
EPS: | $0.450 |
Financial Reports:
No articles found.
Zynex Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.136 | 2014-06-17 |
Last Dividend | $0.100 | 2022-01-05 |
Next Dividend | $0 | N/A |
Payout Date | 2022-01-21 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.300 | -- |
Avg. Dividend % Per Year | 0.21% | -- |
Score | 2.67 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.49 | |
Div. Directional Score | 7.84 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0.136 | 42.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0.0636 | 2.14% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0.100 | 1.07% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0528 | 1.500 | 8.94 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0690 | 1.200 | 7.70 | 9.24 | [0 - 0.3] |
returnOnEquityTTM | 0.168 | 1.500 | 9.24 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.000308 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 4.74 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.85 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.41 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.436 | -1.500 | 2.73 | -4.10 | [0 - 0.6] |
interestCoverageTTM | 11.13 | 1.000 | 6.99 | 6.99 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.531 | 2.00 | 9.82 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.495 | 2.00 | 9.75 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.334 | -1.500 | 4.66 | -7.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.792 | 1.000 | 0.136 | 0.136 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0661 | 1.000 | -0.678 | -0.678 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.290 | 1.000 | 9.50 | 9.50 | [0.2 - 2] |
assetTurnoverTTM | 1.307 | 0.800 | 4.62 | 3.70 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.70 | 1.000 | 6.19 | 0 | [1 - 100] |
returnOnEquityTTM | 0.168 | 2.50 | 9.51 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.495 | 2.00 | 9.84 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.531 | 2.00 | 9.82 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.000308 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0.378 | 1.500 | -0.813 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0967 | 1.000 | -0.0814 | 0 | [0.1 - 0.5] |
Total Score | 4.49 |
Zynex Inc
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.